Hospital
Calverthealth Medical Center, INC.
Calverthealth Medical Center, INC. was paid $921K by Medicaid between Jan 2018 and Nov 2024, across 48 billing codes. Its largest line is 99285, emergency room visit (most serious) — 42% of everything it billed.
33Billing provider infoCALVERTHEALTH MEDICAL CENTER, INC.
PRINCE FREDERICK, MD 20678
PRINCE FREDERICK, MD 20678
33aNPI1457389298assigned 06/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$921K
24GClaims54,881
24DCodes billed48
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#34 of 69
Median peer was paid$870K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,008 | $137K | |
| 2019 | 10,124 | $78K | |
| 2020 | 6,570 | $145K | |
| 2021 | 8,068 | $176K | |
| 2022 | 8,207 | $181K | |
| 2023 | 7,052 | $130K | |
| 2024incomplete | 4,852 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 42% | 2,946 | 2,545 | $384K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 2,122 | 1,901 | $230K |
| G0378 | Hospital observation service, per hour | 9.4% | 294 | 258 | $86K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.6% | 7,903 | 6,341 | $61K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.1% | 946 | 870 | $56K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.3% | 1,727 | 1,239 | $39K |
| 84484 | <1% | 3,482 | 2,546 | $9K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,096 | 3,948 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,679 | 2,311 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,882 | 4,251 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 784 | 692 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 944 | 868 | $4K |
36 more codes
| 83735 | <1% | 3,146 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 49 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,477 | $4K |
| 85610 | <1% | 2,054 | $3K | |
| 81001 | <1% | 1,175 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 96 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,137 | $2K |
| 83690 | <1% | 1,081 | $1K | |
| 85730 | <1% | 181 | $941.08 | |
| 85027 | <1% | 177 | $677.43 | |
| 87088 | <1% | 172 | $667.24 | |
| 82948 | <1% | 1,911 | $631.95 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 79 | $595.44 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 128 | $492.52 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 998 | $429.30 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 548 | $398.03 |
| 81003 | <1% | 1,183 | $341.13 | |
| 83880 | <1% | 133 | $231.81 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 12 | $110.71 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 27 | $105.94 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $88.73 |
| 94760 | <1% | 233 | $30.32 | |
| 83605 | <1% | 47 | $18.18 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 29 | $2.48 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 145 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 39 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 46 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 14 | $0.00 |
| 85379 | 0% | 24 | $0.00 | |
| 82077 | 0% | 50 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 40 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 28 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 15 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 565 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 12 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHEITHAUS, CAROLYN (CFO)
Parent organizationCALVERT HEALTH SYSTEM, INC
| Provider | Location | Paid |
|---|---|---|
| Calverthealth Medical Group, LLC | Prince Frederick, MD | $3.26M |
| CHMG Corelife, LLC | Waldorf, MD | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.